Table 1 Baseline characteristics of patients in normal-MM and low-MM groups
Characteristic | Normal-MM (n = 1477) | Low-MM (n = 2191) | p-value |
|---|---|---|---|
Demographic characteristics | |||
 Age (years) | 60.3 ± 9.7 | 63.8 ± 9.8 |  < 0.001 |
 Age ≥ 60 years, n (%) | 790 (53.5) | 1471 (67.1) |  < 0.001 |
 Female, n (%) | 489 (33.1) | 696 (31.8) | 0.415 |
 BMI(kg/m2) | 23.5 ± 3.0 | 24.0 ± 3.5 | 0.072 |
 Smoking, n (%) | 529 (35.8) | 857 (39.1) | 0.043 |
 Alcohol drinking, n (%) | 601 (40.7) | 914 (42.7) | 0.232 |
Medical history and clinical condition | |||
 Hypertension, n (%) | 877 (59.4) | 1329 (60.7) | 0.458 |
 CHF, n (%) | 129 (8.7) | 197 (9.0) | 0.834 |
 CAD, n (%) | 1178 (79.8) | 1705 (77.8) | 0.173 |
 Stroke, n (%) | 85 (5.8) | 125 (5.7) | 1.000 |
 COPD, n (%) | 3 (0.2) | 19 (0.9) | 0.019 |
 Anemia, n (%) | 375 (25.4) | 651 (29.7) | 0.005 |
Laboratory examination | |||
 Scr/Scys | 1.13 ± 0.27 | 0.77 ± 0.14 |  < 0.001 |
 Scr(mg/dl) | 0.93 ± 0.18 | 0.85 ± 0.19 |  < 0.001 |
 Cystatin C(mg/L) | 0.84 ± 0.17 | 1.13 ± 0.26 |  < 0.001 |
 eGFR(ml/min/1.73m2) | 83.59 ± 16.68 | 92.72 ± 22.89 |  < 0.001 |
 FBG(mmol/L) | 8.99 ± 4.18 | 9.74 ± 4.61 |  < 0.001 |
 2hPBG(mmol/L) | 11.83 ± 4.43 | 12.51 ± 4.65 | 0.009 |
 HbA1C (%) | 7.58 ± 1.57 | 7.69 ± 1.64 | 0.089 |
 TG(mmol/L) | 1.51 (1.10, 2.16) | 1.44 (1.07, 2.04) | 0.004 |
 TC(mmol/L) | 4.57 ± 1.26 | 4.49 ± 1.17 | 0.070 |
 HDL-C(mmol/L) | 0.98 ± 0.25 | 0.96 ± 0.24 | 0.011 |
 LDL-C(mmol/L) | 2.81 ± 0.95 | 2.75 ± 0.94 | 0.047 |
Medications at discharge | |||
 OADs, n (%) | 773 (53.0) | 1137 (52.5) | 0.788 |
 Statins, n (%) | 1313 (90.0) | 1918 (88.5) | 0.176 |
 Aspirin, n (%) | 1222 (83.8) | 1751 (80.8) | 0.026 |
 ACEI/ARB, n (%) | 618 (42.4) | 975 (45.0) | 0.125 |
 CCB, n (%) | 279 (19.1) | 475 (21.9) | 0.046 |